Development of a novel predictive model for interstitial lung disease in ANCA-associated vasculitis prognostications within the Chinese population

Mingwei Fan,Pengfei Li,Yu Wang,Yue Li,Wenjing Zhao,Ruhao Wu,Xiaoying Tian,Mengting Zhang,Zhe Cheng
DOI: https://doi.org/10.1097/md.0000000000037048
IF: 1.6
2024-02-10
Medicine
Abstract:The spectrum of systemic disorders known as antineutrophil cytoplasmic antibody-associated vasculitis (AAV) primarily affects small vessels. It involves eosinophilic granulomatosis with polyangiitis, microscopic polyangiitis, and granulomatosis with polyangiitis. The disease exhibits an annual incidence ranging from approximately 10 to 25 cases per million population, and recent study have indicated a consistent upward trend in the yearly incidence of AAV. [ 1 ] AAV, characterized as an autoimmune disorder, manifests its impact across various organs including the lungs, kidneys, skin, heart, and peripheral nervous system, among others. Research by Smith et al [ 2 ] highlighted that the pulmonary system is affected in more than 80% of AAV cases. Moreover, some diagnoses of AAV have been accompanied by lung involvement, even as the first manifestation, and are closely related to clinical prognosis. [ 3 ] An earlier retrospective study reported a significantly elevated 5-year mortality rate among AAV patients with interstitial lung disease (ILD) in contrast to their counterparts devoid of ILD. [ 4 ] However, there is a paucity of substantial evidence concerning the mortality risk linked to AAV-ILD. Consequently, a validated risk assessment is urgently required to enhance understanding and facilitate the management of AAV-ILD patients.
medicine, general & internal
What problem does this paper attempt to address?